Related Experiment Video
Updated: Jul 26, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Hepatotoxicity in acute iron poisoning
1University of Manitoba, Children's Hospital, Winnipeg, Canada. mtenenbein@hsc.mb.ca
Journal of Toxicology. Clinical Toxicology
|January 10, 2002
Summary
Acute iron poisoning can cause severe liver damage (hepatotoxicity) early in its course, leading to high mortality. This liver injury appears to be dose-related and affects specific liver regions, impacting regeneration and survival.
Area of Science:
- Toxicology
- Hepatology
- Clinical Medicine
Background:
- Hepatotoxicity is a known complication of acute iron poisoning.
- Existing literature is limited to case reports, lacking details on prognosis and dose-dependency.
- Understanding the mechanisms of iron-induced liver injury is crucial for effective interventions.
Purpose of the Study:
- To review the literature and experimental data on hepatotoxicity following acute iron poisoning.
- To elucidate the early clinical presentation, prognosis, and dose-related nature of this condition.
- To identify the specific patterns of liver injury and their implications for mortality.
Main Methods:
- Comprehensive review of existing case reports on iron poisoning-induced hepatotoxicity.
- Analysis of experimental animal studies investigating iron's effects on the liver.
- Correlation of serum iron concentrations with observed hepatotoxicity and mortality rates.
Main Results:
- Hepatotoxicity in acute iron poisoning occurs early and is associated with a high mortality rate.
- The lowest serum iron concentration linked to hepatotoxicity was 1700 microg/dL, suggesting a dose-related effect.
- Injury predominantly affects the periportal areas of the liver lobule, a key site for regeneration.
Conclusions:
- Acute iron poisoning poses a significant risk of early-onset, high-mortality hepatotoxicity.
- The periportal injury pattern contributes to the poor prognosis due to impaired hepatic regeneration.
- Clinical vigilance for hepatotoxicity and early consideration of liver transplantation are essential for managing severe cases.
Related Concept Videos
01:14Prevention of Further Absorption of Poison
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...